Commonwealth Equity Services’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,129
| Closed | -$13K | – | 3727 |
|
|
2022
Q3 | $13K | Sell |
10,129
-885
| -8% | -$1.14K | ﹤0.01% | 3604 |
|
|
2022
Q2 | $24K | Buy |
11,014
+45
| +0.4% | +$98 | ﹤0.01% | 3554 |
|
|
2022
Q1 | $34K | Sell |
10,969
-1,054
| -9% | -$3.27K | ﹤0.01% | 3617 |
|
|
2021
Q4 | $50K | Sell |
12,023
-4,636
| -28% | -$19.3K | ﹤0.01% | 3531 |
|
|
2021
Q3 | $135K | Sell |
16,659
-2,264
| -12% | -$18.3K | ﹤0.01% | 3364 |
|
|
2021
Q2 | $142K | Buy |
18,923
+1,738
| +10% | +$13K | ﹤0.01% | 3346 |
|
|
2021
Q1 | $149K | Hold |
17,185
| – | – | ﹤0.01% | 3203 |
|
|
2020
Q4 | $136K | Hold |
17,185
| – | – | ﹤0.01% | 3018 |
|
|
2020
Q3 | $137K | Buy |
17,185
+1,400
| +9% | +$11.2K | ﹤0.01% | 2818 |
|
|
2020
Q2 | $156K | Sell |
15,785
-200
| -1% | -$1.98K | ﹤0.01% | 2684 |
|
|
2020
Q1 | $123K | Hold |
15,985
| – | – | ﹤0.01% | 2534 |
|
|
2019
Q4 | $61K | Hold |
15,985
| – | – | ﹤0.01% | 2786 |
|
|
2019
Q3 | $80K | Sell |
15,985
-2,000
| -11% | -$10K | ﹤0.01% | 2705 |
|
|
2019
Q2 | $118K | Buy |
17,985
+300
| +2% | +$1.97K | ﹤0.01% | 2617 |
|
|
2019
Q1 | $133K | Sell |
17,685
-750
| -4% | -$5.64K | ﹤0.01% | 2553 |
|
|
2018
Q4 | $148K | Sell |
18,435
-200
| -1% | -$1.61K | ﹤0.01% | 2414 |
|
|
2018
Q3 | $240K | Buy |
18,635
+1,200
| +7% | +$15.5K | ﹤0.01% | 2360 |
|
|
2018
Q2 | $199K | Buy |
+17,435
| New | +$199K | ﹤0.01% | 2466 |
|